Skip to main content
. 2019 Oct 17;7(4):153. doi: 10.3390/vaccines7040153

Table 3.

Serum bactericidal assay. Bacterial killing a and serum titers b.

N. gonorrhoeae Strains
Sera Groups F62 U08401 U08402 FA1090 c
NHS alone 3% 6% 3% 0%
Adjuvant control 0% (1/10) 14% (1/10) 8% (1/10) 0% (1/10)
NGO0416 9% (1/10) 28% (1/10) 8% (1/10) 30% (1/5)
NGO0690 53% (1/40) 50% (1/10) 46% (1/20) 45% (1/10)
NGO0948 50% (1/10) 50% (1/10) 52% (1/10) 57% (1/5)
NGO1043 46% (1/10) 55% (1/10) 48% (1/10) 13% (1/5)
NGO1215 17% (1/10) 57% (1/10) 23% (1/10) 0% (1/5)
NGO1701 50% (1/40) 55% (1/10) 46% (1/20) 52% (1/5)

a % inverse of survival (CFU T0/CFU T30); b reciprocal of the sera dilution that kills 50% or more bacteria; c 20% NHS.